Role of PAR-2 Receptor in Intestinal Inflammation
Author Information
Author(s): Patel MB, Patel MA, Shah GB
Primary Institution: Shree Sarvajanik Pharmacy College, Mahesana, India
Hypothesis
The study investigates the role of PAR-2 receptor activation in the pathophysiology of intestinal inflammation.
Conclusion
Trypsin increases the severity of inflammatory bowel disease by activating PAR-2 receptors in the colon.
Supporting Evidence
- Trypsin treatment resulted in significant reductions in body weight, food intake, and water intake compared to the control group.
- Animals treated with trypsin showed increased colon weight and severity of inflammation compared to those treated only with TNBS.
- Histopathological analysis indicated increased disease activity index and colonic mucosal damage index in trypsin-treated animals.
Takeaway
This study found that a substance called trypsin makes gut inflammation worse by affecting special receptors in the intestines.
Methodology
Wistar albino rats were used to study the effects of trypsin on intestinal inflammation induced by TNBS.
Limitations
The study was conducted on a small sample size of rats, which may limit the generalizability of the findings.
Participant Demographics
Adult Wistar albino rats of either sex weighing between 200 and 250 g.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website